Anti-Anxiety Drugs Industry Size and Forecast Through 2032
Read More => https://dataintelo.com/rep...
According to Dataintelo, the global anti-anxiety drugs market is poised for substantial growth, projected to reach USD 23.8 billion by 2032, growing at a CAGR of 5.4% from 2024 to 2032.
Increasing mental health awareness, coupled with rising cases of anxiety disorders, is one of the primary drivers of this market. Governments and private healthcare providers worldwide are expanding access to mental health services, resulting in higher diagnosis and treatment rates. Furthermore, growing social acceptance of psychiatric medication is encouraging more individuals to seek pharmacological intervention for anxiety.
Read More => https://dataintelo.com/rep...
According to Dataintelo, the global anti-anxiety drugs market is poised for substantial growth, projected to reach USD 23.8 billion by 2032, growing at a CAGR of 5.4% from 2024 to 2032.
Increasing mental health awareness, coupled with rising cases of anxiety disorders, is one of the primary drivers of this market. Governments and private healthcare providers worldwide are expanding access to mental health services, resulting in higher diagnosis and treatment rates. Furthermore, growing social acceptance of psychiatric medication is encouraging more individuals to seek pharmacological intervention for anxiety.
Anti-Anxiety Drugs Market Report | Global Forecast From 2025 To 2033
The global anti-anxiety drugs market size was valued at approximately USD 12.4 billion in 2023 and is expected to reach USD 18.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.6% during the forecast period.
https://dataintelo.com/report/global-anti-anxiety-drugs-market
11:50 AM - May 07, 2025 (UTC)
